Unveiling 7 Analyst Insights On Avidity Biosciences
Cantor Fitzgerald Reiterates Overweight on Avidity Biosciences, Maintains $96 Price Target
Avidity Biosciences(RNA.US) Officer Sells US$4.5 Million in Common Stock
$Avidity Biosciences(RNA.US)$ Officer Flanagan W. Michael sold 111.39K shares of common stock on Sep 11, 2024 at an average price of $40.3993 for a total value of $4.5 million.Source: Announcement
Avidity Biosciences Insider Sold Shares Worth $1,010,043, According to a Recent SEC Filing
Wells Fargo Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $75
Wells Fargo analyst Yanan Zhu maintains $Avidity Biosciences(RNA.US)$ with a buy rating, and maintains the target price at $75.According to TipRanks data, the analyst has a success rate of 33.5% and
Avidity Biosciences: Strong Buy on Promising Clinical Data and Reduced Competition